Grade |
Control group |
% |
Experimental group |
% |
| 0 |
82 patients |
68.3% |
87 patients |
72.5% |
| Ia |
0 patients |
00% |
1 patients |
3.0% |
| Ib |
1 patients |
2.6% |
1 patients |
3.0% |
| Ic |
2 patients |
5.3% |
0 patients |
00% |
| IIa |
1 patients |
2.6% |
2 patients |
6.1% |
| IIb |
2 patients |
5.3% |
0 patients |
00% |
| IIc |
0 patients |
00% |
2 patients |
6.1% |
| IId |
2 patients |
5.3% |
0 patients |
00% |
| IIIa |
1 patients |
2.6% |
1 patients |
3.0% |
| IIIb |
4 patients |
10.5% |
3 patients |
9.1% |
| IIIc |
5 patients |
13.2% |
4 patients |
12.1% |
| IIId |
7 patients |
18.4% |
9 patients |
27.3% |
| IVa |
1 patients |
2.6% |
0 patients |
00% |
| IVb |
8 patients |
21.1% |
7 patients |
21.2% |
| V |
4 patients |
10.5% |
3 patients |
9.1% |
|
